Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors

Patent 12083124 was granted and assigned to Incyte on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

1

Patent attributes

Patent Applicant

1

Current Assignee

1

Patent Jurisdiction

United States Patent and Trademark Office

1

Patent Number

Patent Inventor Names

Oleg Vechorkin1

Michael Witten1

Chao Qi1

Ke Zhang1

Yao Xu1

Wenqing Yao1

Peng Zhao1

Hai Fen Ye1

...

Date of Patent

September 10, 2024

1

Patent Application Number

181597981

Date Filed

January 26, 2023

1

Patent Citations

US Patent 7642255 Compounds and compositions as protein kinase inhibitors

1

US Patent 7648973 2-methylene-1α,25-dihydroxy-19,21-dinorvitamin D

1

US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

1

US Patent 6998408 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors

1

US Patent 7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof

1

US Patent 7125880 Corticotropin releasing factor antagonists

1

US Patent 7488802 Antibodies against PD-1

1

US Patent 7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof

1

...

Patent Primary Examiner

Samantha L Shterengarts

1

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool